We are live on ! Find out more
IONS icon

Ionis Pharmaceuticals
IONS

173 hedge funds and large institutions have $2.84B invested in Ionis Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 173 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

22% more call options, than puts

Call options by funds: $36M | Put options by funds: $29.5M

Holders
173
Holders Change
+173
Holders Change %
–
% of All Funds
5.65%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.1%
New
173
Increased
–
Reduced
–
Closed
–
Calls
$36M
Puts
$29.5M
Net Calls
+$6.51M
Net Calls Change
+$6.51M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
151
BlackRock
New York
$95K +$75.2K +3,537 New
TRCT
152
Tower Research Capital (TRC)
New York
$94K +$74.4K +3,501 New
US Bancorp
153
US Bancorp
Minnesota
$84K +$66.3K +3,117 New
RNS
154
Robert N. Shapiro
$76K +$60.2K +2,830 New
GT
155
Glenmede Trust
Pennsylvania
$76K +$60.8K +2,860 New
WIL
156
Winifred I. Li
$70K +$55.1K +2,590 New
Envestnet Asset Management
157
Envestnet Asset Management
Illinois
$63K +$49.5K +2,329 New
MA
158
MUFG Americas
New York
$43K +$34K +1,600 New
OMCS
159
Old Mutual Customised Solutions
South Africa
$40K +$31.9K +1,500 New
Robeco Institutional Asset Management
160
Robeco Institutional Asset Management
Netherlands
$31K +$24.7K +1,160 New
Creative Planning
161
Creative Planning
Kansas
$18K +$13.9K +653 New
PSUF
162
People's United Financial
Connecticut
$13K +$10.6K +500 New
PFPT
163
Pinnacle Financial Partners (Tennessee)
Tennessee
$9K +$7.23K +340 New
PTC
164
Private Trust Company
Ohio
$9K +$7.34K +345 New
PAS
165
Partnervest Advisory Services
California
$8K +$6.06K +285 New
FNBT
166
FineMark National Bank & Trust
Florida
$5K +$3.62K +170 New
JG
167
Jefferies Group
New York
$5K +$4.08K +192 New
KTC
168
Kistler-Tiffany Companies
Pennsylvania
$5K +$4.25K +200 New
PSC
169
Prentiss Smith & Co
Vermont
$5K +$4.25K +200 New
PG
170
PEAK6 Group
Illinois
$3.81K +$3.01M +141,600 New
MFS
171
MSI Financial Services
Massachusetts
$2K +$1.38K +65 New
First Manhattan
172
First Manhattan
New York
$1K +$1.06K +50 New
WA
173
WFG Advisors
Texas
$1K +$1.11K +52 New
3 4 5 6
7

IONS Hedge Fund Activity: Q2 2013 in Review

173 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Ionis Pharmaceuticals (IONS) for Q2 2013, worth a combined $2.84B.

Buyers outnumbered sellers: 173 funds opened new IONS positions and 0 closed out — a net gain of 173 holders — while 0 added to existing stakes and 0 trimmed.

  • 173 institutional investors held Ionis Pharmaceuticals (IONS) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $2.84B of Ionis Pharmaceuticals stock for Q2 2013.
  • 173 funds opened new Ionis Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +173 holders.

Based on aggregated 13F filings for Q2 2013.